ClinicalLung : What is the role of TP53 co-mutation on EGFR-TKI e • TwiCopy

Clinical Lung Cancer

@ClinicalLung

+ Follow

Peer-reviewed journal covering clinical and translational research of lung and other thoracic cancers published by Elsevier. EIC: Antoinette Wozniak MD

calendar_today31-03-2022 17:56:19

75 Tweets

500 Followers

181 Following

Clinical Lung Cancer

@ClinicalLung

1 year ago

What is the role of TP53 co-mutation on EGFR-TKI efficacy?

A study published Clinical Lung Cancer suggests that diverse types of TP53 mutations may have a different impact on the prognosis of EGFR-mutant NSCLC. #LCSM

Find out more: bit.ly/3qb94o4

What is the role of TP53 co-mutation on EGFR-TKI efficacy? A study published @ClinicalLung suggests that diverse types of TP53 mutations may have a different impact on the prognosis of EGFR-mutant NSCLC. #LCSM Find out more: bit.ly/3qb94o4

account_circle